Formulation and Characterization of a New Injectable Bone Substitute Composed PVA/Borax/CaCO and Demineralized Bone Matrix.

The occurrence of bone-related disorders and diseases has dramatically increased in recent years around the world. Demineralized bone matrix (DBM) has been widely used as a bone implant due to its osteoinduction and bioactivity. However, the use of DBM is limited because it is a particulate material, which makes it difficult to manipulate and implant with precision.